Cargando…
Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1
The gut–brain axis is currently being studied as a therapeutic strategy for neurological diseases, especially Alzheimer’s disease (AD). Obesity results in the gut microbiota dysbiosis, which includes butyrate-producing bacteria are reduced. Although sodium butyrate (NaB) has emerged as the potential...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303181/ https://www.ncbi.nlm.nih.gov/pubmed/32555166 http://dx.doi.org/10.1038/s41419-020-2663-1 |
_version_ | 1783547996181364736 |
---|---|
author | Kim, Seo Yihl Chae, Chang Woo Lee, Hyun Jik Jung, Young Hyun Choi, Gee Euhn Kim, Jun Sung Lim, Jae Ryong Lee, Joo Eun Cho, Ji Hyeon Park, Hansoo Park, Changho Han, Ho Jae |
author_facet | Kim, Seo Yihl Chae, Chang Woo Lee, Hyun Jik Jung, Young Hyun Choi, Gee Euhn Kim, Jun Sung Lim, Jae Ryong Lee, Joo Eun Cho, Ji Hyeon Park, Hansoo Park, Changho Han, Ho Jae |
author_sort | Kim, Seo Yihl |
collection | PubMed |
description | The gut–brain axis is currently being studied as a therapeutic strategy for neurological diseases, especially Alzheimer’s disease (AD). Obesity results in the gut microbiota dysbiosis, which includes butyrate-producing bacteria are reduced. Although sodium butyrate (NaB) has emerged as the potential therapeutic substance in AD, there is a lack of detailed results into what signaling pathways affect amyloidogenesis in AD induced by obesity. Thus, we investigated the regulatory role of NaB on amyloidogenesis in neuronal cells under high cholesterol. In our results, we verified that increased amyloid β peptide (Aβ) accumulation in the brain of obese mice and a reduction in butyrate-producing bacteria due to the gut microbiota dysbiosis induced by obesity. We showed that NaB decreased the expression levels of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and Aβ accumulation induced by high cholesterol in SK-N-MC cells. We demonstrated that NaB was absorbed in cells through sodium-coupled monocarboxylate transporter 1 (SMCT1) and then inhibited high cholesterol-induced Aβ accumulation. Subsequently, we also observed that reactive oxygen species (ROS) were overproduced because of increased NADPH oxidase 2 (NOX2) expression under high cholesterol. Meanwhile, NaB decreased NOX2 levels through a reduction of NF-κB activity, which ultimately inhibited Aβ accumulation caused by high cholesterol. We demonstrated that NaB increased the expression levels of p21 under high cholesterol, contributing to p21/NRF2 (Nuclear factor erythroid 2-related factor 2) colocalization, which leads to NRF2 stabilization. NRF2 stabilization causes NF-κB inactivation, followed by NOX2 suppression and superoxide dismutase 1 (SOD1) upregulation. Thus, NaB with SOD1 silencing under high cholesterol did not eliminate excessive ROS, and eventually resulted in Aβ accumulation. In conclusion, we demonstrated that NaB prevents excessive ROS through NOX2 suppression and SOD1 upregulation by p21/NRF2 pathway, which is critical for inhibiting BACE1-dependent amyloidogenesis in neuronal cells exposed to high cholesterol environment. |
format | Online Article Text |
id | pubmed-7303181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73031812020-06-22 Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 Kim, Seo Yihl Chae, Chang Woo Lee, Hyun Jik Jung, Young Hyun Choi, Gee Euhn Kim, Jun Sung Lim, Jae Ryong Lee, Joo Eun Cho, Ji Hyeon Park, Hansoo Park, Changho Han, Ho Jae Cell Death Dis Article The gut–brain axis is currently being studied as a therapeutic strategy for neurological diseases, especially Alzheimer’s disease (AD). Obesity results in the gut microbiota dysbiosis, which includes butyrate-producing bacteria are reduced. Although sodium butyrate (NaB) has emerged as the potential therapeutic substance in AD, there is a lack of detailed results into what signaling pathways affect amyloidogenesis in AD induced by obesity. Thus, we investigated the regulatory role of NaB on amyloidogenesis in neuronal cells under high cholesterol. In our results, we verified that increased amyloid β peptide (Aβ) accumulation in the brain of obese mice and a reduction in butyrate-producing bacteria due to the gut microbiota dysbiosis induced by obesity. We showed that NaB decreased the expression levels of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and Aβ accumulation induced by high cholesterol in SK-N-MC cells. We demonstrated that NaB was absorbed in cells through sodium-coupled monocarboxylate transporter 1 (SMCT1) and then inhibited high cholesterol-induced Aβ accumulation. Subsequently, we also observed that reactive oxygen species (ROS) were overproduced because of increased NADPH oxidase 2 (NOX2) expression under high cholesterol. Meanwhile, NaB decreased NOX2 levels through a reduction of NF-κB activity, which ultimately inhibited Aβ accumulation caused by high cholesterol. We demonstrated that NaB increased the expression levels of p21 under high cholesterol, contributing to p21/NRF2 (Nuclear factor erythroid 2-related factor 2) colocalization, which leads to NRF2 stabilization. NRF2 stabilization causes NF-κB inactivation, followed by NOX2 suppression and superoxide dismutase 1 (SOD1) upregulation. Thus, NaB with SOD1 silencing under high cholesterol did not eliminate excessive ROS, and eventually resulted in Aβ accumulation. In conclusion, we demonstrated that NaB prevents excessive ROS through NOX2 suppression and SOD1 upregulation by p21/NRF2 pathway, which is critical for inhibiting BACE1-dependent amyloidogenesis in neuronal cells exposed to high cholesterol environment. Nature Publishing Group UK 2020-06-18 /pmc/articles/PMC7303181/ /pubmed/32555166 http://dx.doi.org/10.1038/s41419-020-2663-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kim, Seo Yihl Chae, Chang Woo Lee, Hyun Jik Jung, Young Hyun Choi, Gee Euhn Kim, Jun Sung Lim, Jae Ryong Lee, Joo Eun Cho, Ji Hyeon Park, Hansoo Park, Changho Han, Ho Jae Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title | Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title_full | Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title_fullStr | Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title_full_unstemmed | Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title_short | Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1 |
title_sort | sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating nrf2 stabilization-mediated ros levels: involvement of nox2 and sod1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303181/ https://www.ncbi.nlm.nih.gov/pubmed/32555166 http://dx.doi.org/10.1038/s41419-020-2663-1 |
work_keys_str_mv | AT kimseoyihl sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT chaechangwoo sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT leehyunjik sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT jungyounghyun sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT choigeeeuhn sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT kimjunsung sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT limjaeryong sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT leejooeun sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT chojihyeon sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT parkhansoo sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT parkchangho sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 AT hanhojae sodiumbutyrateinhibitshighcholesterolinducedneuronalamyloidogenesisbymodulatingnrf2stabilizationmediatedroslevelsinvolvementofnox2andsod1 |